Attached files

file filename
EX-10.1 - EXHIBIT 10.1 - IMMUNIC, INC.vitaltherapies-firstamendm.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 23, 2016
 
VITAL THERAPIES, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-36201
56-2358443
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
15010 Avenue of Science, Suite 200
San Diego, California 92128
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (858) 673-6840

Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 




Item 1.01    Entry into a Material Definitive Agreement.

On August 23, 2016, Vital Therapies, Inc. (the "Company") entered into an amendment to extend its lease (the "Amended Lease") with BRE CA Office Owner LLC for 19,118 square feet of office space at 15010 Avenue of Science, San Diego, California (the "Building") from August 2017 to January 2019. The Amended Lease does not include an option to extend. The lease payments over the term of the extension will be $724,000. In addition, the Company estimates it will pay approximately $40,000 over the extended term for its proportionate share of the Building's operating expenses.
Item 2.03    Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 above is incorporated by reference into this Item 2.03.
Item 9.01    Financial Statements and Exhibits.
(d) Exhibits
Exhibit No.
 
Description
10.1
 
Amended Lease between BRA CA Office Owner LLC and the Company, dated August 23, 2016






SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
 
VITAL THERAPIES, INC.
 
 
 
 
 
By: /s/ Michael V. Swanson   
 
 
Michael V. Swanson
Chief Financial Officer
Date: August 29, 2016